Aktis Oncology, Inc. Deferred Revenue, Current
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2026-08-13
- 2026-06-30: Deferred Revenue, Current $17.34M.
- 2026-03-31: Deferred Revenue, Current $18.96M.
- 2025-12-31: Deferred Revenue, Current $18.66M.
| Period end | Deferred Revenue, Current |
|---|---|
| 2026-06-30 | $17.34M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $18.96M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $18.66M 10-Q · filed 2026-08-13 |